Stereotaxis Inc (STXS)

Currency in USD
2.240
-0.050(-2.18%)
Real-time Data·
STXS Scorecard
Full Analysis
Stock price movements are quite volatile
STXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.2302.288
52 wk Range
1.5402.716
Key Statistics
Prev. Close
2.29
Open
2.26
Day's Range
2.23-2.288
52 wk Range
1.54-2.716
Volume
102.03K
Average Volume (3m)
390.49K
1-Year Change
27.22%
Book Value / Share
0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STXS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.500
Upside
+100.89%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Stereotaxis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Stereotaxis Inc Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Stereotaxis Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue of $7.5M, up 9% YoY, beating forecasts. EPS of -$0.07 met expectations. Stock rose 1.45% in aftermarket trading.
  • European approval for MAGIC RF Ablation Catheter, adopted in 20% of European hospitals. U.S. approval pending.
  • Projecting double-digit revenue growth for 2025. System revenue expected at $2-3M quarterly, recurring revenue to reach $7M by Q4.
  • CEO emphasizes strategic transformation and technology advancement. Genesis X system to contribute modestly to revenue.
  • Risks include regulatory delays, competition in electrophysiology sector, and potential slow adoption of new technologies.
Last Updated: 12/05/2025, 22:30
Read Full Transcript

Compare STXS to Peers and Sector

Metrics to compare
STXS
Peers
Sector
Relationship
P/E Ratio
−7.8x−3.7x−0.5x
PEG Ratio
0.42−0.240.00
Price/Book
71.9x2.7x2.6x
Price / LTM Sales
7.5x3.1x3.3x
Upside (Analyst Target)
96.5%47.7%43.5%
Fair Value Upside
Unlock4.0%6.3%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.500
(+100.89% Upside)

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.07 / -0.07
Revenue / Forecast
7.47M / 6.83M
EPS Revisions
Last 90 days

STXS Income Statement

People Also Watch

265.08
AVAV
-1.07%
25.00
VCYT
+2.80%
3.465
IMRX
+1.02%
2.205
VOR
+4.50%
26.01
CNC
-0.78%

FAQ

What Stock Exchange Does Stereotaxis Trade On?

Stereotaxis is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Stereotaxis?

The stock symbol for Stereotaxis is "STXS."

What Is the Stereotaxis Market Cap?

As of today, Stereotaxis market cap is 207.37M.

What Is Stereotaxis's Earnings Per Share (TTM)?

The Stereotaxis EPS (TTM) is -0.31.

When Is the Next Stereotaxis Earnings Date?

Stereotaxis will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is STXS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Stereotaxis Stock Split?

Stereotaxis has split 2 times.

How Many Employees Does Stereotaxis Have?

Stereotaxis has 139 employees.

What is the current trading status of Stereotaxis (STXS)?

As of 05 Aug 2025, Stereotaxis (STXS) is trading at a price of 2.24, with a previous close of 2.29. The stock has fluctuated within a day range of 2.23 to 2.29, while its 52-week range spans from 1.54 to 2.72.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.